Aprea Therapeutics APRE
NASDAQ APRE
$0.77 +0.03 (+3.97%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aprea Therapeutics (APRE) Operating Leases (2019 - 2022)

Updated

Aprea Therapeutics (APRE) recorded Operating Leases of $28,061 in Q1 2022, down 16.9% from $33,763 a year earlier.

Analysis

Aprea Therapeutics (APRE) Operating Leases (2019 - 2022) Analysis & Trends

At the end of FY2020, Aprea Therapeutics reported Operating Leases of $78,847, down 73.9% from FY2019.

  • Across earlier years, Operating Leases came in at $302,621 in FY2019.
  • The Q1 2022 figure is the lowest quarterly Operating Leases in data going back to Q3 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Aprea Therapeutics 40.11 Mn 40.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 28,061.00
Sep 30, 2021 29,773.00
Mar 31, 2021 33,763.00
Dec 31, 2020 78,847.00
Sep 30, 2020 132,773.00
Jun 30, 2020 185,926.00
Mar 31, 2020 227,288.00
Dec 31, 2019 302,621.00
Sep 30, 2019 358,404.00
API Access

Aprea Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=APRE&period=max&api_key=YOUR_API_KEY